Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Articles from Mary Thompson:

Business Strategies

At Long Last, Renal Denervation Hits the US Market; What Can We Expect?

In November, FDA approved renal denervation systems from Medtronic and Recor Medical as adjunctive treatments for people with hypertension. The label is broad, and the technology addresses a huge unmet need, but just how far, and how fast, will this new device market go?

Read Article